Cargando…
Thermosensitive Exosome–Liposome Hybrid Nanoparticle‐Mediated Chemoimmunotherapy for Improved Treatment of Metastatic Peritoneal Cancer
Metastatic peritoneal carcinoma (mPC) is a deadly disease without effective treatment. To improve treatment of this disease, a recently developed hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as the standard of care. However, the efficacy of this approach is limited by inefficient dr...
Autores principales: | Lv, Qijun, Cheng, Lili, Lu, Yao, Zhang, Xiaoge, Wang, Yizhen, Deng, Junfeng, Zhou, Jiangbing, Liu, Bo, Liu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509655/ https://www.ncbi.nlm.nih.gov/pubmed/32999828 http://dx.doi.org/10.1002/advs.202000515 |
Ejemplares similares
-
Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
por: Lin, Yao, et al.
Publicado: (2018) -
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
por: Liu, Yusheng, et al.
Publicado: (2022) -
In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis
por: Wang, Xinyue, et al.
Publicado: (2022) -
Review of the Delivery Kinetics of Thermosensitive Liposomes
por: Haemmerich, Dieter, et al.
Publicado: (2023) -
Current developments in drug delivery with thermosensitive liposomes
por: Bi, Hongshu, et al.
Publicado: (2019)